Stock Ratings / Health Care / ELV / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Elevance Health Inc. (ELV) 12-Month Stock Forecast & Price Target Cone

$422.02 +1.84% NYSE • Public Delayed / 60s Snapshot

Elevance Health Inc. (ELV) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.

ROARABLE C- • HOLD / WATCH Cap $91.18B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+1.4% Base Target

WHALE OPTIONS TUG-OF-WAR:61% Call Buyers ($9.9M)

39% PutsMax Pain: $414.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your ELV Position Size: $10,000

Shares at $422.02: 23.7 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $333.62

$7,905

$-2,095 (-20.9%)

12M Consensus BaseTarget $427.72

$10,135

+$135 (+1.4%)

12M Bull Case BreakoutTarget $504.71

$11,959

+$1,959 (+19.6%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$445	74%	A
Goldman SachsSector Coverage Lead	BUY	$474	69%	B
JP MorganUS Large-Cap Research	HOLD	$381	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live ELV Tape Review)

✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

ELV // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +11.60%▲ ASCENDING CHANNEL

2026-10-30O $425.0H $426.8L $416.5C $420.1VOL 1.29M

RES: $452.1SUP: $381.6SMA50: $410.6SMA200: $372.4

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ELV Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ELV Butterfly Map → + Track ELV →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.7%/yr Implied 5Y Growth

vs. +12.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ELV today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ELV. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ELV today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

ELV Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is ELV's 12-month stock price target?

Elevance Health Inc. (ELV) carries a 12-month consensus base price target of $427.72 (+1.4% from $422.02), with a bull-case target of $504.71 and a bear-case floor of $333.62.